{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T11:16:51Z","timestamp":1715080611326},"reference-count":49,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:p>The present study was aimed at evaluating the effectiveness of amoxicillin-bearing HSA (human serum albumin) and PLGA [poly(lactic-co-glycolic acid)] microparticles in combating Listeria monocytogenes infection in Swiss albino mice. Amoxicillin-bearing HSA microspheres were prepared by chemical cross-linking of a drug\/albumin mixture with glutaraldehyde, and PLGA microspheres were prepared by the W\/O\/W (water-in-oil-in-water) emulsion technique. The microspheres were characterized for their size, \u03b6 potential and entrapment efficiency using SEM (scanning electron microscopy) and a Zetasizer. Release kinetics was performed in a phosphate buffer (pH\u00a07.4) at 37\u00b0C simulating physiological conditions. Bacterial burden in various vital organs and survival data established enhanced efficacy of PLGA and HSA microspheres as compared with free drug. Among the two delivery systems, PLGA microspheres, when compared with HSA microspheres, imparted better efficacy in terms of reduction in bacterial load as well as increase in survival. The results of the present study clearly demonstrate that microparticles successfully target the infected macrophages and the approach could be well exploited for targeting the intracellular pathogens as well.<\/jats:p>","DOI":"10.1042\/bsr20100027","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T08:22:39Z","timestamp":1281082959000},"page":"265-272","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Amoxicillin-bearing microparticles: potential in the treatment of <i>Listeria monocytogenes<\/i> infection in Swiss albino mice"],"prefix":"10.1042","volume":"31","author":[{"given":"Mohammad","family":"Farazuddin","sequence":"first","affiliation":[{"name":"Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh-202002, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh-202002, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raza\u00a0M.M.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Aligarh Muslim University, Aligarh-202002, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Owais","sequence":"additional","affiliation":[{"name":"Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh-202002, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2011,3,2]]},"reference":[{"key":"2021111618060777700_B1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/oxfordjournals.aje.a115893","article-title":"The epidemiology of listeriosis in the United States \u2013 1986","volume":"133","author":"Gellin","year":"1991","journal-title":"Am. J. Epidemiol."},{"key":"2021111618060777700_B2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1749-6632.1970.tb45580.x","article-title":"Listeria infections","volume":"174","author":"Louria","year":"1970","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2021111618060777700_B3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0950268800059355","article-title":"Human listeriosis in Britain, 1967\u201385, a summary of 722 cases. 2. Listeriosis in nonpregnant individuals, a changing pattern of infection and seasonal incidence","volume":"104","author":"McLauchlin","year":"1990","journal-title":"Epidemiol. Infect."},{"key":"2021111618060777700_B4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00365549609037921","article-title":"Listeriosis in 225 non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions","volume":"28","author":"Goulet","year":"1996","journal-title":"Scand. J. Infect. Dis."},{"key":"2021111618060777700_B5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/clinids\/20.1.66","article-title":"An epidemic of food-borne listeriosis in Western Switzerland: description of 57 cases involving adults","volume":"20","author":"Bula","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"2021111618060777700_B6","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200004273421702","article-title":"An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes","volume":"342","author":"Aureli","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"2021111618060777700_B7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S0950268800059343","article-title":"Human listeriosis in Britain, 1967\u201385, a summary of 722 cases. 1. Listeriosis during pregnancy and in the newborn","volume":"104","author":"McLauchlin","year":"1990","journal-title":"Epidemiol. Infect."},{"key":"2021111618060777700_B8","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/jama.1992.03480150047035","article-title":"Role of foods in sporadic listeriosis I. Case-control study of dietary risk factors. JAMA, J","volume":"267","author":"Schuchat","year":"1992","journal-title":"Am. Med. Assoc."},{"key":"2021111618060777700_B9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF01646117","article-title":"Lack of synergism of ampicillin and gentamicin in experimental listeriosis","volume":"15","author":"Hof","year":"1987","journal-title":"Infection"},{"key":"2021111618060777700_B10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF01639741","article-title":"Antibiotic susceptibilities of Listeria: in vitro studies","volume":"2","author":"Espaze","year":"1988","journal-title":"Infection"},{"key":"2021111618060777700_B11","first-page":"1","article-title":"Infections caused by Listeria: an update","volume":"12","author":"Brown","year":"1989","journal-title":"Infect. Dis. Pract"},{"key":"2021111618060777700_B12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656566.5.8.1727","article-title":"An update on the medical management of listeriosis","volume":"5","author":"Hof","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"2021111618060777700_B13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1345\/aph.19315","article-title":"Treatment of listeriosis","volume":"34","author":"Temple","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"2021111618060777700_B14","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/jcm.29.11.2606-2608.1991","article-title":"Feeding trials of Listeria monocytogenes with a nonhuman primate model","volume":"29","author":"Farber","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"2021111618060777700_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/24.1.1","article-title":"Listeriosis","volume":"24","author":"Lorber","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"2021111618060777700_B16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00005792-199809000-00002","article-title":"Central nervous system infection with Listeria monocytogenes. 33\u00a0years experience at a general hospital and review of 776 episodes from the literature","volume":"77","author":"Mylonakis","year":"1998","journal-title":"Medicine"},{"key":"2021111618060777700_B17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/0140-6736(90)91447-I","article-title":"Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes","volume":"335","author":"Poyart-Salmeron","year":"1990","journal-title":"Lancet"},{"key":"2021111618060777700_B18","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1128\/AAC.46.7.2095-2103.2002","article-title":"Comparative intracellular (THP-1 macrophage) and extracellular activities of \u03b2-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations","volume":"46","author":"Carryn","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618060777700_B19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dki094","article-title":"Activity of three \u03b2-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus","volume":"55","author":"Lemaire","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"2021111618060777700_B20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/AAC.38.3.438","article-title":"Inhibition of intracellular growth of Listeria monocytogenes by antibiotics. Antimicrob","volume":"38","author":"Michelet","year":"1994","journal-title":"Agents Chemother."},{"key":"2021111618060777700_B21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/10611860903450007","article-title":"Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach","volume":"18","author":"Dangi","year":"2010","journal-title":"J. Drug Target."},{"key":"2021111618060777700_B22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1574-695X.2005.00014.x","article-title":"Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice","volume":"46","author":"Khan","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2021111618060777700_B23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dki454","article-title":"Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model","volume":"57","author":"Nasti","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"2021111618060777700_B24","first-page":"26","article-title":"Biodegradable controlled-release parenteral systems","volume":"8","author":"Tice","year":"1984","journal-title":"J. Pharm. Technol."},{"key":"2021111618060777700_B25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.progpolymsci.2007.04.001","article-title":"Polymeric protein delivery systems","volume":"32","author":"Lee","year":"2007","journal-title":"Prog. Polym. Sci."},{"key":"2021111618060777700_B26","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/iai.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect. Immun."},{"key":"2021111618060777700_B27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0264-410X(93)90387-D","article-title":"Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles","volume":"11","author":"O'Hagan","year":"1993","journal-title":"Vaccine"},{"key":"2021111618060777700_B28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0168-3659(94)90263-1","article-title":"Degradation of poly(DL-lactic acid) microspheres: effect of molecular weight","volume":"30","author":"Park","year":"1994","journal-title":"J. Contr. Rel."},{"key":"2021111618060777700_B29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0142-9612(93)90066-B","article-title":"Poly(L-lactide): a long-term degradation study in vivo. Part I: Biological results","volume":"14","author":"Pistner","year":"1993","journal-title":"Biomaterials"},{"key":"2021111618060777700_B30","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jps.2600631044","article-title":"Albumin microspheres as vehicles for achieving specificity in drug delivery","volume":"63","author":"Kramer","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"2021111618060777700_B31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/02652048609031564","article-title":"Streptomycin sulphate microspheres: formulation and in vivo distribution","volume":"3","author":"G\u00fcrkan","year":"1986","journal-title":"J. Microencapsul."},{"key":"2021111618060777700_B32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/02652049009040474","article-title":"Cyclophosphamide loaded albumin microspheres. II. Release characteristics","volume":"4","author":"Vural","year":"1990","journal-title":"J. Microencapsul."},{"key":"2021111618060777700_B33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1023\/A:1018980020506","article-title":"The preparation and characterization of PLGA microspheres: II. The entrapment of model protein using (water in oil) in water emulsion solvent evaporation technique","volume":"10","author":"Jeffery","year":"1993","journal-title":"Pharm. Res."},{"key":"2021111618060777700_B34","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1023\/A:1015948829632","article-title":"Release of human serum albumin from PLGA microspheres","volume":"7","author":"Hora","year":"1990","journal-title":"Pharm. Res."},{"key":"2021111618060777700_B35","volume-title":"Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard, Document M2-A6","author":"National Committee for Clinical Laboratory Standards","year":"1997","edition":"6th edn"},{"key":"2021111618060777700_B36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.42.9.2375","article-title":"In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations","volume":"42","author":"Andes","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618060777700_B37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.00004-06","article-title":"Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics","volume":"41","author":"Abgueguen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111618060777700_B38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0014-5793(93)81760-W","article-title":"Tuftsin bearing liposomes as drug vehicles in the treatment of experimental aspergillosis","volume":"326","author":"Owais","year":"1993","journal-title":"FEBS Lett."},{"key":"2021111618060777700_B39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/02652040802211717","article-title":"Evaluation of albumin microspheres as oral delivery system for Mycobacterium tuberculosis vaccines","volume":"26","author":"Yeboah","year":"2009","journal-title":"J. Microencapsul."},{"key":"2021111618060777700_B40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2008.09.011","article-title":"Serum albumin-alginate coated microspheres: role of the inner gel in binding and release of the KRFK peptide","volume":"366","author":"Ma\u00eft\u00e9\u00a0Callewaert","year":"2009","journal-title":"Int. J. Pharm."},{"key":"2021111618060777700_B41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(92)90193-U","article-title":"Release of proteins via ion exchange from albumin-heparin microspheres","volume":"22","author":"Kwon","year":"1992","journal-title":"J. Control. Release"},{"key":"2021111618060777700_B42","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1128\/AAC.48.9.3246-3252.2004","article-title":"Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres. Antimicrob","volume":"48","author":"Sa'nchez-Brunete","year":"2004","journal-title":"Agents Chemother."},{"key":"2021111618060777700_B43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/jsre.1999.5686","article-title":"Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats","volume":"86","author":"Fallon","year":"1999","journal-title":"J. Surg. Res."},{"key":"2021111618060777700_B44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5173(87)90207-9","article-title":"Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids","volume":"39","author":"Burgess","year":"1987","journal-title":"Int. J. Pharm."},{"key":"2021111618060777700_B45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0168-3659(94)90130-9","article-title":"Adriamycin loading and release characteristics of albumin-heparin conjugate microspheres","volume":"29","author":"Cremers","year":"1994","journal-title":"J. Control. Release"},{"key":"2021111618060777700_B46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3748\/wjg.v5.i1.57","article-title":"Preparation and distribution of 5-fluorouracil [125I] sodium alginate\u2013bovine serum albumin nanoparticles","volume":"5","author":"Yi","year":"1999","journal-title":"World J. Gastroenterol."},{"key":"2021111618060777700_B47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/10611860008997908","article-title":"In-vitro and in-vivo efficacy of acid sensitive transferrin and albumin doxorubicin conjugates in human xenograft panel and in the MDA-MB-435 mamma carcinoma model","volume":"8","author":"Kratz","year":"2000","journal-title":"J. Drug Target."},{"key":"2021111618060777700_B48","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1345\/aph.19315","article-title":"Treatment of listeriosis","volume":"34","author":"Temple","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"2021111618060777700_B49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/CMR.10.2.345","article-title":"Management of listeriosis","volume":"10","author":"Hof","year":"1997","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/31\/4\/265\/474678\/bsr0310265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/31\/4\/265\/474678\/bsr0310265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T18:15:46Z","timestamp":1637086546000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/31\/4\/265\/55830\/Amoxicillin-bearing-microparticles-potential-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,2]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20100027","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,2]]}}}